End-to-end SaaS platform of blockchain-integrated software solutions for clinical trials.
Triall has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Triall's investors include Zokyo.
Triall is headquartered in Maarssen, The Netherlands.
End-to-end SaaS platform of blockchain-integrated software solutions for clinical trials.
Triall is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Triall — Funding & Investors." VCBacked, July 1, 2021, https://www.vcbacked.co/company/triall. Accessed August 14, 2026.
VCBacked. (2021). Triall — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/triall
{{cite web |title=Triall — Funding & Investors |url=https://www.vcbacked.co/company/triall |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated